遺伝子工学の進歩
オープンアクセス

概要

マレーシアにおける遺伝子組み換え技術転換に関するバイオセーフティ法への生命倫理的配慮の統合

シティ・ハフシア・イドリス

 In considering the use of modern biotechnology, particularly genetically modified organisms (GMOs), the Malaysian Government is aware of the great potential benefits as well as the uncertainties, risks and doubts of this emerging technology. While the great benefits of this technology can help meet future needs, this technology is often accompanied by public debate regarding its potential risks, including bioethical issues. Mitigating these risks in a sustainable manner requires a biosafety framework to protect human, plant and animal health, the environment and biodiversity.

One of the means to manage the risks is the rule of justice under law as a decisive technical solution. The government passed the Biosafety Law in 2007. It serves as an “umbrella law” and includes the establishment of the National Biosafety Commission, as well as legal and institutional provisions tailored to comply with the Cartagena Protocol, and aims to regulate the import, export, intentional release, contained use, and marketing of GMO-related products in order to protect human, plant, and animal health, the environment, and biodiversity. The question is how does this law address bioethical issues and how effective is the law in addressing these issues? The purpose of this paper is to analyze how effectively this 2007 Biosafety Law and its regulations integrate bioethical issues related to GM crops in realizing its objectives. This article focuses specifically on the provisions of bioethical issues of GMOs under the law and its regulations.